We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

QRS fragmentation and T-wave inversion as factors of vulnerability to recurrent ventricular tachycardia

    Fani Zagkli

    Cardiology Department, Patras University Hospital, Patra, Greece

    ,
    Alexandra Georgakopoulou

    Cardiology Department, Patras University Hospital, Patra, Greece

    &
    John Chiladakis

    *Author for correspondence: Tel.:/Fax: +011 6972 859 168;

    E-mail Address: chil@otenet.gr

    Cardiology Department, Patras University Hospital, Patra, Greece

    Published Online:https://doi.org/10.2217/fca-2017-0104

    Clinical manifestation of late onset recurrent monomorphic ventricular tachycardia (VT) in patients with normal left ventricular ejection fraction may elude diagnosis despite elaborate testing. This report describes a 67-year-old woman with structurally normal heart who presented with recurrent VT in the absence of predisposing factors. Repeated extensive diagnostic testing, including magnetic resonance imaging and coronary angiography, did not disclose any abnormality. An implantable cardioverter-defibrillator was placed following noninducibility of the third episode of VT at electrophysiological study. Patient's 12-lead electrocardiogram in normal sinus rhythm revealed permanent QRS fragmentation as well as T-wave inversions as the only warning features that heralded the impending appearance of recurrent VTs over the course of 5 years follow-up.

    References

    • 1 Goldberger JJ, Cain ME, Hohnloser SH et al. AHA/ACC/HRS statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death. Circulation 118(14), 1497–1518 (2008).
    • 2 Das MK, Khan B, Jacob S, Kumar A, Mahenthiran J. Significance of a fragmented QRS complex versus a Q-wave in patients with coronary artery disease. Circulation 113(21), 2495–2501 (2006).
    • 3 Das MK, Maskoun W, Shen C et al. Fragmented QRS on twelve-lead electrocardio-gram predicts arrhythmic events in patients with ischemic and nonischemic cardiomyopathy. Heart Rhythm 7(1), 74–80 (2010).
    • 4 Wang DD, Tibrewala A, Nguygen P et al. Fragmented QRS on surface electrocardiogram is not a reliable predictor of myocardial scar, angiographic coronary disease or long term adverse outcomes. Cardiovasc. Diagn. Ther. 4(4), 279–286 (2014).
    • 5 Terho HK, Tikkanen JT, Junttila JM et al. Prevalence and prognostic significance of fragmented QRS complex in middle-aged subjects with and without clinical or electrocardiographic evidence of cardiac disease. Am. J. Cardiol. 114(1), 141–147 (2014).
    • 6 Aro AL, Anttonen O, Tikkanen JT et al. Prevalence and prognostic significance of T-wave inversions in right precordial leads of a 12-lead electrocardiogram in the middle-aged subjects. Circulation 125(21), 2572–2577 (2012).
    • 7 Rosengarten JA, Scott PA, Morgan JM. Fragmented QRS for the prediction of sudden cardiac death: a meta-analysis. Europace 17(6), 969–977 (2015).
    • 8 Priori SG, Gasparini M, Napolitano C et al. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J. Am. Coll. Cardiol. 59(1), 37–45 (2012).
    • 9 Peters S, Trümmel M, Koehler B. QRS fragmentation in standard ECG as a diagnostic marker of arrhythmogenic right ventricular dysplasia-cardiomyopathy. Heart Rhythm 5(10), 1417–1421 (2008).
    • 10 Sher T, Gertz MA. Recent advances in the diagnosis and management of cardiac amyloidosis. Future Cardiol. 10(1), 131–146 (2014).